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Introduction
More severe mental illnesses, like depres-
sion, are connected with various cardiovas-
cular risk factors, like hypertension, obesity, 
atherogenic dyslipidemia, hyperglycemia, 
smoking and alcohol and other psychoactive 
Abstract – There is a growing quantity of data showing that mental illnesses affect the somatic health. De-
pression is a complex disease, connected with the disturbances of sleep-cycle, appetite, body weight and 
level of physical activity, all of which may represent the risk factors for the development of metabolic distur-
bances. In the depressive patients, there is a number of various physiological mechanisms and psychosocial 
factors which may influence the development of metabolic syndrome (MS), such as sex, age, smoking, stress 
levels, nutrition and level of physical activity. It is considered that chronic stress causes depression and the 
resulting bad life habits may lead to MS and finally KVB. Aim of this study was to investigate the psychosocial 
and clinical features of depressive patients with the diagnosis of MS. The cross-reference study has been 
done at the sample of 80 patients diagnosed with MS. Among the diagnostic instruments applied, we have 
used the structured socio-demographic questionnaire, MINI questionnaire, Hamilton Rating Scale for De-
pression (HAMD-17) and Clinical Global Impression (CGI). The diagnosis of metabolic syndrome had been es-
tablished following the NCEP ATP criteria. Among the depressive patients, there were 38.8% who fulfilled the 
criteria for establishing the diagnosis of MS. There was a greater incidence of suicide among the depressive 
patients with the diagnosis of MS. The diagnose was more frequently established in depressive women, while 
an increased intake of carbohydrates represented a significant feature of both depression and MS. Further 
research is needed to explain the observed gender differences and to determine if the interventions aimed 
to treating the depression can also contribute to accepting the healthy life habits and as a consequence, in-
directly reduce the incidence of MS.
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substances abuse. Patients suffering from the 
depressive disorder display alterations of  cir-
cadian rhythm, sleep disturbances, changes 
of  autonomic nervous system, hypothala-
mus-hypophysis-adrenal gland axis (HHN) 
hyperactivity and changes of  immunologic 
system. On the other hand, the somatic dis-
eases, like obesity, hyperlipidemia, hyperten-
sion and diabetes mellitus type II are lately 
ever more often accepted as significant co-
morbid states in patients with more severe 
mental diseases. There is ever more data 
showing that the severe mental illnesses also 
affect the somatic health and only lately, these 
states are evaluated in the context of  meta-
bolic syndrome. Pathogenesis of  metabolic 
syndrome, similar to pathogenesis of  depres-
sion, is complex and insufficiently investigat-
ed. However, it is considered that the interac-
tions of  chronic stress, psychological trauma, 
hypercortisolism and disturbed immunologic 
functions contribute to the development of  
these disturbances [1-6].
Metabolic syndrome (MS) is a complex 
multisystem disturbance, consisting of  sev-
eral components, namely: abdominal obesity, 
lipid metabolism dysfunction, hypertension 
and glucose metabolism dysfunction [7]. Be-
sides that, the syndrome is connected with 
pro-inflammatory and pro-thrombotic state, 
resulting from the secretory activity of  fat 
tissue, characterized by an increased level 
of  inflammation mediators, endothelial dys-
function, hyperfibrinogenaemia, increased 
aggregation of  thrombocytes, increased con-
centration of  plasminogen activation inhibi-
tors, increased levels of  uric acid and micro-
albuminuria. MS represents the greatest risk 
for diabetes and cardiovascular diseases. MS 
was described in patients with polycystic ova-
ries syndrome, non-alcoholic steatosis of  the 
liver, microalbuminuria and chronic renal 
failure [7-10].
Depression is a complex disease, con-
nected with alterations of  sleep, appetite, 
body weight and level of  physical activity, 
all of  which can represent risk factors for 
the development of  metabolic disturbances. 
In depressive patients, various physiological 
mechanisms can influence the development 
of  metabolic syndrome, such as disturbed 
regulation of  HHN axis and noradrener-
gic system, as well as various psycho-social 
factors, such as gender, age, smoking, stress 
levels, nutrition and level of  physical activ-
ity [11-14]. It is possible that MS represents 
a connection between depression on one 
and KVB and diabetes on the other side. It 
is considered that chronic stress causes de-
pression and consequently harmful lifestyle, 
which can lead to MS and consequently, de-
velopment of  KVB [15]. Disturbed regula-
tion of  HHN axis is typically connected to 
chronic stress and numerous studies had de-
scribed such connection between depression 
and high levels of  cortysole [16-18]. On the 
other hand, increased levels of  cortysole are 
connected with components of  metabolic 
syndrome, such as the abdominal obesity and 
glucose intolerance, so depression can indi-
rectly influence the metabolism of  glucose 
and the risk of  diabetes development [19,20]. 
Besides that, psycho-social variables, such as 
depressive mood, can result in changes of  
levels of  pro-inflammatory cytokines, which 
are also important components for the devel-
opment of  metabolic syndrome [21].
Based on the research so far, we may say 
that the depressive patients show a greater 
incidence of  cardiovascular diseases, hyper-
tension and diabetes compared to the other 
psychiatric patients and the general popula-
tion [22-39]. Symptoms of  a depressive dis-
turbance are frequently observed among the 
patients with MS and fatigue is a frequent 
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symptom in states with a chronic activation 
of  non-specific immunity, such as MS [39-
43].
The aim of  this study was to determine 
the psychosocial and clinical features of  de-
pressive patients diagnosed with MS.
Patients and methods
Patients
A cross-sectional study has been done 
on the sample of  80 patients suffering from 
depressive disorder. From that total num-
ber, 40 of  these subjects suffered from the 
melancholic type of  the depressive disor-
der, while 40 had been classified as a non-
melancholic depression. In the investigation 
were  included patients of  both genders with 
no other somatic diseases besides the com-
ponents of  metabolic syndrome and with no 
other psychiatric diseases but the co-morbid 
depressive disorder. In the group with de-
pressive patients, there were 46 males and 34 
females, mean age 50.03 ± 9.35 years, mean 
onset of  depression at the age of  44.6 ± 9.18 
years, mean duration of  depression 6.08 ± 
4.92 years, mean number of  depressive epi-
sodes 2.21 ± 1.98 and the average result on 
HAMD—17 26.6 ± 9.72. Only the patients 
who had been at least three months off  
any psychiatric therapy were included in the 
study. All patients suitable for the study had 
been presented with the aim and the purpose 
of  investigation and they were asked to sign 
an informed consent for participation in it. 
The control group consisted of  healthy vol-
unteers of  both genders, suffering from no 
somatic or psychiatric diseases, who had also 
given an informed consent for the participa-
tion in this study. Members of  the control 
group had been recruited from hospital staff  
and it consisted of  40 subjects, 15 males and 
25 females, mean age 45.5 ± 9.37 years, aver-
aging 3.44 ± 2.06 on HAMD-17. Those pa-
tients who had not given the informed con-
sent or had been proved to suffer  from some 
other co-morbid psychiatric disturbance, ad-
diction to alcohol or other psychoactive sub-
stances or any other somatic disease that 
does not belong among the components of  
MS and those who had used the anti-inflam-
matory medications were not included in the 
study.
Diagnostic instruments
For the purpose of  this study, we have 
used a structured questionnaire, consisting 
of  socio-demographic and history variables, 
such as: sex, age, level of  education, work sta-
tus, marital status, place of  residence, family 
heredity of  depressive disturbances, age of  
the onset of  the first episode, duration of  the 
disease, total number of  episodes of  the de-
pressive disorder, smoking, alcohol and feed-
ing habits.
All patients included into he study had 
been diagnosed with the depressive disorder, 
i.e. all other psychiatric diagnostic categories 
had been excluded using MINI questionnaire 
(Mini International Neuropsychiatric Inter-
view). MINI is a short structured interview, 
developed in the collaboration of  European 
and the American clinical psychiatrists, tai-
lored after DSM IV and MKB 10 classifica-
tions of  psychiatric disturbances [44] MINI 
questionnaire had been used also to deter-
mine the type of  the depressive disorder 
(melancholic and non-melancholic).
As an additional diagnostic means in es-
tablishing the diagnosis and estimating the 
severity of  the depressive disorder (mild, 
moderate and severe), Hamilton’s evaluation 
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scale (Hamilton’s Rating Scale for Depression 
HAND-17) had been used. This evaluation 
scale dates from the 1960 but is still, despite 
the fifty years of  use, the most frequently ap-
plied and one of  the most popular scales for 
depression [45].
For the estimation of  severity of  depres-
sive episodes and the response to treatment, 
the psychiatric rating scale Clinical Global 
Impression (CGI) had been used [46].
The diagnosis of  metabolic syndrome was 
established according to NCEP ATP III cri-
teria [47] and they had been chosen because 
they had been applied in most of  the  previ-
ous investigations. According to that defini-
tion, MS was confirmed in patients who satis-
fied three or more of  following criteria:
1. Central obesity (waist circumference > 
102 cm in men, > 88 cm in women)
2. Elevated triglycerides (>= 1.7 mmol/L or 
requiring the fibrates in therapy)
3. High blood pressure (systolic >= 130 or 
diastolic >= 85 mm of  Hg or requiring 
the pharmaceutical control of  hyperten-
sion)
4. Increased morning levels of  blood sugar 
(>= 6.11 mmol/L or previously known 
diagnosis of  Type II diabetes)
5. Reduced levels of  HDL cholesterol (< 
1.04 mmol/L for men, < 1.3 mmol/L for 
women or requiring the use of  fibrates in 
therapy)
Clinical examination and anthropometric 
measures
All subjects had their systolic and diastolic 
blood pressure measured on the forearm, us-
ing a mercury sphygmomanometer immedi-
ately after 30 minutes of  relaxation. Height 
and weight were measured using a hospital 
scale, with patients wearing light clothes and 
with no shoes. The waist circumference was 
measured using a tailors’ measuring meter at 
the level  between the last rib and crista iliaca, 
on the bare skin, while expiring. All measured 
have been done three time in a row and then 
the mean values have been calculated. Gener-
al medical and neurological examination had 
been used to exclude other somatic and neu-
rologic diseases.
Statistical analysis
The results obtained have been processed 
using descriptive, parametric and non-para-
metric methods, according to the distribu-
tion of  data. Categorical variables have been 
shown in descriptive statistics as frequen-
cies and percentages, while the continuous 
variables have been shown as the arithmetic 
means and standard deviations. The differ-
ences in socio-demographic variables have 
been determined using Chi-Square Test and 
Fisher’s Exact Test. The differences in clinical 
characteristics have been determined using 
Student’s T-Test and Chi-Square Test. Deter-
mining the intergroup differences in variables 
of  lifestyle has been done using Chi-Square 
Test. Fisher’s Exact Test and Kruskall Wallis 
test. Distribution of  data has been tested us-
ing Kolmogorov-Smirnoff  Test. Statistically 
significant levels were set at p<0.05.
SPSS statistical software, v. 15 has been 
used for all statistical analyses (SPSS, Chica-
go, IL).
Results
Socio-demographic features of the sample 
In this study, 28.4% of  all subjects had been 
found to satisfy the NCEP ATP III criteria for 
MS diagnosis. The depressive patients fulfilled 
the criteria for MS and all of  its components 
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in  significantly greater proportion compared 
to the control group. 38.8% of  depressive 
subjects had fulfilled the criteria for establish-
ing the diagnosis of  MS (p<0.001).
The main features of  the samples have 
been shown in Table 1. As he Table shows, 
Table 1 Socio-demographic characteristics of  patients suffering from the depressive disorder with 
and without metabolic syndrome.
Variable Diagnosis of  metabolic syndrome p
No Yes
Age (X±SD) 49.43±8.34 50.97±10.84 0.477†
Sex N (%) 0.045‡
M 33 (67.3) 13 (41.9)
Ž 16 (32.7) 18 (58.1)
Level of  education  N (%) 0.750‡
Primary 7 (14.3) 4 (12.9)
Secondary 31 (63.3) 22 (71)
University 11 (22.4) 5 (16.1)
Marriage N (%) 0.093*
Not married 10 (20.4) 3 (9.7)
Married 35 (71.4) 21 (67.7)
Divorced 3 (6.1) 2 (6.5)
Widower 1 (2) 5 (16.1)
Work N (%) 0.072‡
Unemployed 7 (14.3) 6 (19.4)
Employed 30 (61.2) 11 (35.5)
Retired 12 (24.5) 14 (45.2)
Place of  residence N (%) 0.218‡
City 30 (63.8) 13 (46.4)
Village 17 (36.2) 15 (53.6)
Smoking N (%) 0.555‡
Not smoking 28 (60.9) 18 (62.1)
Smoking 17 (37) 9 (31)
Abstinent 1 (2.2) 2 (6.9)
the incidence of  metabolic syndrome was sig-
nificantly higher among women. There were 
no significant inter-group differences consid-
ering their age, level of  education, work and 
marital status, place of   residence, smoking, 
alcohol drinking and alimentary habits.
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Clinical characteristics of the sample
The subjects with metabolic syndrome 
showed much higher results on scales of  
depression and anxiety and a significantly 
higher number of  suicide attempts in 
history, although there were no significant 
differences considering the suicide risk 
estimate (Table 2).
Variable Diagnosis of  metabolic syndrome p
No Yes
Alcohol N (%) 0.183*
Does not drink 39 (84.8) 22 (75.9)
Occasionally 7 (15.2) 5 (17.2)
Abstinent 0 (0) 2 (6.9)
Alimentary habits  N (%) 0.405‡
<40 % CH 2 (6.1) 0 (0)
40-60 % CH 21 (63.6) 13 (59.1)
>60 % CH 10 (30.3) 9 (40.9)
†Student’s t-test; ‡Chi-Square Test; *Fisher’s Exact Test
Table 1 (Continued from previous page)
Table 2 Clinical characteristics of  the sample of  patients suffering from the depressive disorder 
with and without metabolic syndrome.
Variable Diagnosis of  metabolic syndrome p
No Yes
HAM-D 17 (X±SD) 17.5±14.04 25.3±9.96 0.002a
HAM-A (X±SD) 16.16±12.12 22.15±9.98 0.028a
Risk of  suicide N (%) 0.051b
No risk 47 (55.3) 10 (29.4)
Low 10 (11.8) 6 (17.6)
Moderate 12 (14.1) 5 (14.7)
High 16 (18.8) 13 (38.2)
Suicide attempts  (X±SD) 0.19±0.49 0.53±0.89 0.041a
aStudent’s T-test; bChi-Square Test 
However, when only the depressive pa-
tients had been analyzed, the previously ob-
served differences in results of  depression 
and anxiety rating scales and suicide attempts 
were gone and there were also no differences 
considering the onset age of  depression, du-
ration of  depression, number of  depressive 
episodes, suicide risk estimate and results on 
CGI-S and CGI-C rating scales (Table 3).
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Differences in smoking habits, alcohol 
drinking and carbohydrate percentage 
in food, depending on the depression-
related parameters. 
Smoking habits amongst the subjects have 
been shown in Table 4. The subjects who es-
tablished the abstinence from smoking have 
scored much higher on anxiety scales, while 
there were no significant differences consid-
ering the depression and other clinical vari-
ables shown. 
The alcohol-drinking subjects amongst 
the subjects depending on depression and 
anxiety-related parameters have been shown 
Table 3 Clinical characteristics of  patients suffering from the depressive disorder with and without 
metabolic syndrome.
Variable Diagnosis of  metabolic syndrome p
No Yes
Age of  depression onset (X±SD) 44.2±8.08 45.21±10.75 0.651a
Duration of  depression (X±SD) 5.55±4.99 6.9±4.78 0.254a
Number of  episodes (X±SD) 1.89±1.75 2.71±2.24 0.085a
HAM-D 17 (X±SD) 27.5±9.58 25.3±9.96 0.334a
HAM-A (X±SD) 23.03±11.5 22.15±9.98 0.754a
CGI-S (X±SD) 5.24±0.92 5.32±0.86 0.730a
CGI-C (X±SD) 2.28±0.75 2.71±0.92 0.140a
Suicide risk N (%) 0.773b
No risk 10 (20.8) 7 (22.6)
Low 10 (20.8) 6 (19.4)
Moderate 12 (25) 5 (16.1)
High 16 (33.3) 13 (41.9)
Suicide attempts (X±SD) 0.33±0.62 0.58±0.92 0.184a
aStudent’s T-test; bChi-Square Test 
Table 4 Differences in smoking habits depending on the depression-related parameters.
Variable Smoking χ2 p
Does not smoke Smokes Abstinent
Type of  depression N (%) 1,785 0,447†
Melancholy 26 (56.5) 11 (42.3) 1 (33.3)
Non-melancholy 20 (43.5) 15 (57.7) 2 (66.7)
Number of  episodes (X±SD) 2.32±2.17 2.42±1.79 1±0 3.016 0.221‡
Duration of  depression (X±SD) 6.14±4.46 6.08±5.53 6±6.93 0.365 0.833‡
24
Alcoholism and Psychiatry Research 2016;52:17-32 Martinac, Bevanda, Bevanda-Glibo, Tomić, Bevanda, Vasilj
in Table 5. Using the Kruskal-Wallis Test, we 
have found significant differences between 
the groups tested in results scored on depres-
sion rating scales, while there were no sig-
nificant differences in other variables shown. 
To determine the difference between the in-
dividual groups, we have used the Kruskal-
Wallis Z-Test. We have found a statistically 
significant difference in the level of  depres-
sion between the subjects who do not drink 
alcohol and those who reported to drink oc-
casionally (z= 3.0727).
Alimentary habits depending on depres-
sion and anxiety-related parameters have 
been shown in Table 6. The subjects who had 
reported a greater percentage of  carbohy-
drates in their food scored significantly high-
er on depression and anxiety rating scales, 
while there were no significant differences 
concerning the other clinical variables. 
Variable Smoking χ2 p
Does not smoke Smokes Abstinent
Age of  depression onset (X±SD) 45.43±9.78 42.83±7.94 52.67±4.16 4.244 0.120‡
Suicide  attempts (X±SD) 0.23±0.48 0.42±0.91 0.33±0.58 0.628 0.731‡
HAMD-17 (X±SD) 18.44±14.08 20.46±12.91 20.67±1.15 0.583 0.747‡
HAMA (X±SD) 15.7±12.03 19.55±10.74 28±5.57 6.598 0.037‡
† Fisher’s Exact Test, ‡Kruskal Wallis test
Table 4 (Continued from previous page)
Table 5 Differences in alcohol drinking depending on depression-related parameters.
Variable Alcohol χ2 p




Type of  depression N (%) 0.725 0.768†
Melancholy 32 (52.5) 5 (41.7) 1 (50)
Non-melancholy 29 (47.5) 7 (58.3) 1 (50)
Number of  episodes (X±SD) 2.33±2.18 2±1 3±0 1.703 0.456‡
Duration of  depression (X±SD) 6.05±4.96 6.64±5.08 5±0 0.182 0.916‡
Age of  depression onset (X±SD) 45±9.1 42.73±9.55 52±8.48 1.729 0.448‡
Suicide attempts (X±SD) 0.27±0.57 0.38±0.87 0±0 0.567 0.753‡
HAMD-17 (X±SD) 21.39±12.66 13.21±14.45 19.5±0.71 9.446 0.005‡
HAMA (X±SD) 18.8±10.68 15.69±13.68 23±0.57 3.668 0.122‡
† Fisher’s Exact Test, ‡Kruskal Wallis Test
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To determine the differences between the 
individual groups, Kruskal-Wallis Z-test had 
been used. We have found statistically signifi-
cant differences in depression levels accord-
ing to HAMD-17, i.e. the patients who had 
reported <40 % of  carbohydrates in their 
nutrition scored much lower on depression 
scales compared to the patients with 40-60 
% of  carbohydrates in nutrition (z=2.594) 
and to the patients with >60 % of  carbohy-
drates in nutrition (z=2.181). Besides that, 
we have found a statistically significant dif-
ference in anxiety levels according to HAMA 
scale, i.e. the subjects  who had reported <40 
% of  carbohydrates in their nutrition scored 
significantly lower on the scale compared to 
the subjects with 40-60 % of  carbohydrates 
in nutrition (z=3.054), while the subjects with 
40-60% of  carbohydrates scored much high-
er on anxiety scale compared to the subjects 
with >60 % of  carbohydrates in their nutri-
tion (z=2.108).
Differences in smoking habits, alcohol 
drinking and carbohydrate percentage 
in nutrition depending on MS and its 
components 
The subjects who reported themselves 
as smokers fulfilled in significantly greater 
percentage the NCEP ATP-III criteria for 
hypertriglyceridaemia (p=0.012), while the 
abstinents showed a significantly larger per-
centage of  hyperglycemia (p=0.05). There 
were no significant differences neither  con-
sidering the levels of  HDL-cholesterol in se-
rum, nor considering the abdominal obesity, 
hypertension, number of  components and 
the diagnose of  MS (Table 7).
The alcohol-drinking habits amongst the 
subjects depending on MS and its compo-
Table 6 Differences in alimentary habits depending on depression-related parameters.
Variable Nutrition χ2 p
<40 % CH 40-60 % CH >60 % CH
Type of  depression N (%) 2.685 0.261†
Melancholy 2 (100) 14 (41.2) 8 (42.1)
Non-melancholy 0 (0) 20 (58.8) 11 (57.9)
Number of  episodes (X±SD) 5±4.24 2.26±1.69 2.61±2.66 1.571 0.456‡
Duration of  depression (X±SD) 12.5±13.43 6.97±5.23 5.56±3.91 1.106 0.575‡
Age of  depression onset (X±SD) 40.5±2.12 44±8.69 45.33±10.78 1.202 0.548‡
Suicide attempts (X±SD) 0.08±0.29 0.33±0.73 0.23±0.43 1.395 0.498‡
HAMD-17 (X±SD) 8.17±10.35 19.52±13,47 19.67±11.18 6.935 0.031‡
HAMA (X±SD) 10.58±8.01 22.05±12.05 13.5±9.87 11.333 0.003‡
†Chi-Square Test, ‡Kruskal Wallis Test
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nents have been shown in Table 8. No signif-
icant differences were observed considering 
the parameters tested. 
The subjects who reported a greater 
percentage of  carbohydrates in their nutri-
tion fulfilled the NCEP ATP-III criteria 
for abdominal obesity (p<0.011), hyperten-
sion (p<0.006) and hypertriglyceridaemia 
(p<0.009) in significantly larger percentage, 
reported significantly more components of  
MS (p<0.001) and met the criteria for estab-
lishing the diagnosis of  metabolic syndrome 
in much greater number (p=0.033). There 
were no significant differences considering 
the levels of  glucose and HDL-cholesterol in 
serum (Table 9).
Table 7 Differences in smoking habits depending on MS and its components.
Variable N (%) Smoking χ2 p
Does not smoke Smokes Abstinent
Abdominal obesity 23 (32.4) 14 (36.8) 2 (66.7) 1.868 0.404†
Hypertension 38 (53.5) 16 (42.1) 3 (100) 3.864 0.120†
Hyperglycemia 9 (12.7) 3 (7.9) 2 (66.7) 6.166 0.035†
Hypertriglyceridaemia 27 (38) 25 (65.8) 1 (33.3) 7.918 0.012†
Low HDL 12 (16.9) 11 (28.9) 1 (33.3) 2.836 0.246†
Number of  components (X±SD) 1.54±1.21 1.82±1.5 3±1.73 2.996 0.224‡
MS 18 (25.4) 12 (31.6) 2 (66.7) 2.676 0.207†
†Fisher’s Exact Test, ‡Kruskal Wallis Test
Table 8 Differences in alcohol drinking habits depending on MS and its components
Variable N (%) Alcohol χ2 p
Does not drink Drinks  occasionally Abstinent
Abdominal obesity 28 (35.9) 9 (28.1) 2 (100) 3.786 0.115†
Hypertension 40 (51.3) 15 (46.9) 2 (100) 1.783 0.559†
Hyperglycemia 13 (16.7) 1 (3.1) 0 (0) 4.009 0.105†
Hypertriglyceridaemia 38 (48.7) 13 (40.6) 2 (100) 2.480 0.299†
Low HDL 15 (19.2) 9 (28.1) 0 (0) 1.369 0.580†
Number of  components 
(X±SD) 1.72±1.26 1.47±1.52 3±0 3.878 0.144
‡
MS 22 (28.2) 8 (25) 2 (100) 4.212 0.139†
†Fisher’s Exact Test, ‡Kruskal Wallis Test
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Discussion
In this study, from the total number of  
subjects tested, we have found 28.4% who 
satisfy the NCEP ATP III criteria for MS 
diagnosis. Depressive patients have fulfilled 
the criteria for the diagnosis of  MS and all of  
its components in significantly greater per-
centage compared to the control group, i.e. 
38.8% of  depressive patients met the criteria 
for establishing the diagnosis of  MS. 
The depressive subjects in this study were 
significantly older than the subjects from the 
control group, they were more often single, 
unemployed and with a much greater per-
centage of  carbohydrates in their diet. Sub-
jects with MS were of  lower level of  educa-
tion, unemployed, with significantly greater 
percentage of  carbohydrates in their diet. 
Contrary to the similar investigation on hos-
pitably treated subjects, where the patents 
with MS had been significantly older than the 
patients without MS [48], there were no such 
differences observed in our group of  sub-
jects. These findings also contradict the stud-
ies in which an increased incidence of  MS 
had been found in patients of  later ages [7]. 
Among the depressive patients, females have 
significantly more frequently fulfilling the cri-
teria for MS, which is in concordance with 
investigation of  correlation of  depression 
and MS on a sample of  young adults, which 
had showed that younger women with at least 
one depressive episode in their histories had 
significantly higher probability of  developing 
MS compared to those who had no depres-
sive episodes in their histories [39].
Depressive patients have met the crite-
ria for establishing the diagnosis of  MS and 
all of  its components in significantly greater 
percentage compared to the control group, 
i.e. 38.8% of  depressive patients have fulfilled 
the criteria for MS diagnosis, which is in con-
cordance with data published by Jakovljević 
et al. In their review paper in 2007 [1]. Sub-
jects with MS scored much higher on depres-
sion and anxiety scales, which is similar as 
found by other researchers [49] and had a sig-
nificantly greater number of  suicide attempts 
in their histories, as opposed to the similar 
investigation on a sample of  hospitally-treat-
Table 9 Differences in alimentary habits depending on MS and its components
Variable N (%) Nutrition χ2 p
<40 % CH 40-60 % CH
>60 % 
CH
Abdominal obesity 2 (16.7) 14 (26.9) 13 (59.1) 8.972 0.011†
Hypertension 2 (16.7) 24 (46.2) 16 (72.7) 10.145 0.006†
Hyperglycemia 1 (8.3) 7 (13.5) 2 (9.1) 0.435 0.805†
Hypertriglyceridaemia 0 (0) 23 (44.2) 11 (50) 9.334 0.009†
Low HDL 0 (0) 11 (21.2) 5 (22.7) 3.213 0.201†
Number of  components (X±SD) 0.42±0.67 1.52±1.41 2.14±1.17 15.662 <0.001‡
MetS 0 (0) 13 (25) 9 (40) 6.849 0.033†
†Chi-Square Test, ‡Kruskal Wallis Test
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ed patients, where the group of  patients with 
MS had a significantly lower number of  sui-
cides [50]. The same study reported that the 
group of  patients with metabolic syndrome 
had shorter depressive episodes, while in this 
study, no significant differences were ob-
served between the patients with and without 
MS neither considering the age of  depression 
onset, nor duration of  depression, number 
of  depressive episodes, suicide risk estimate 
and CGI-S and CGI-C scales results, which is 
in concordance with the investigation carried 
out by Capuron et al. in 2008 [51], which also 
had not revealed any significant differences 
between the patients with and without MS 
considering the history of  previous depres-
sive episodes, suggesting that the depressive 
simptomatology in MS is more related to the 
immediate medical and metabolic condition 
than with any pre-morbid characteristics of  
either the depression or the personality itself  
[51]. 
Previous studies have shown that depres-
sion can be connected to bad alimentary 
habits and can be sporadically related to an 
excessive intake of  calories under the influ-
ence of  psychological distress caused by the 
depression itself  [52-54]. According to the 
results of  this study, the level of  depression 
was connected with greater percentage of  
carbohydrates in patients’ diet. The great-
er percentage of  carbohydrates also meant 
a greater incidence of  abdominal obesity, 
hypertension, hypertriglyceridaemia, more 
components of  MS and significantly more 
frequent diagnosis of  MS. Several previous 
studies have shown that smoking is more 
prevalent amongst the depressive patients 
[52,55,56]. Contrary to the previous stud-
ies, we have sound no differences in smok-
ing habits between the depressive patients 
and the control group, while those who had 
reported an absolute abstinence of  alcohol 
showed the greatest levels of  depression ac-
cording to HAMD-17. Those subjects who 
reported themselves as smokers fulfilled the 
NCEP ATP-III criteria for hypertriglyceri-
daemia in significantly larger number, while 
there were no significant differences in alco-
hol drinking habits depending on the pres-
ence of  MS. 
Conclusively, the results of  this study have 
shown a greater incidence of  suicide amongst 
the depressive patients diagnosed with MS. 
From the psycho-social variables tested, we 
might say that the diagnosis of  MS was more 
frequently established in depressive females. 
There is no adequate explanation for this in 
currently available scientific literature, so fur-
ther studies are required to clarify these sex-
related differences. Besides that, an increased 
intake of  carbohydrates was a significant fea-
ture of  both depression and MS in this study, 
which is a fact that requires further prospec-
tive studies do clarify if  the interventions 
aimed at treating the depression could also 
contribute to accepting the healthy lifestyle, 
especially changing the dietary habits and 
consequentially, if  the depression treatment 
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Psihosocijalne i kliničke karakteristike depresivnih bolesnika s dijagnozom 
metaboličkog sindroma
Sažetak – Sve je više podataka koji pokazuju da teže mentalne bolesti imaju utjecaja i na tjelesno zdravlje. 
Depresija je kompleksna bolest povezana s promjenama u spavanju, apetitu, tjelesnoj težini i razini tjele-
sne aktivnosti što sve mogu biti rizični faktori za razvoj metaboličkih poremećaja. U depresivnih na razvoj 
metaboličkog sindroma mogu utjecati različiti fiziološki mehanizmi ali i različiti psihosocijalni čimbenici kao 
što su spol, dob, pušenje, razina stresa, ishrana, razina fizičke aktivnosti.  Smatra se da kronični stres uzrokuje 
depresiju i posljedični loš životni stil koji može voditi u MS i posljedično razvoj KVB. Cilj ovog istraživanja bio 
je istražiti psihosocijalna i klinička obilježja depresivnih bolesnika s dijagnozom MS. Provedena je presječna 
studija na uzorku od 80 bolesnika s dijagnozom depresivnog poremećaja. Od dijagnostičkih instrumenata 
korišten je strukturirani sociodemografski upitnik, te MINI upitnik, Hamilton rating scale for depression 
(HAMD-17) i Clinical Global Impression (CGI). Dijagnoza metaboličkog sindroma se postavljala prema NCEP 
ATP III kriterijima. Postotak depresivnih ispitanika koji su zadovoljavali kriterije za dijagnozu MS bilo je 38,8%. 
Nađena je veća učestalost suicida u depresivnih ispitanika s dijagnozom MS, dijagnoza MS se značajno češće 
postavljala u depresivnih žena, pojačan unos ugljikohidrata je bio značajno obilježje i depresivnosti i MS. 
Potrebna su daljnja istraživanja u svrhu objašnjenja uočenih spolnih razlika, te da li intervencije usmjerene 
ka liječenju depresije mogu doprinositi prihvaćanju zdravih stilova života, posebno promjeni prehrambenih 
navika i tako neizravno doprinositi smanjenju pojavnosti MS.
Ključne riječi: depresija, metabolički sindrom, psihosocijalni faktori

